Author: Senti Biosciences, Inc.

Posted Date:

April 13, 2026

Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026

Senti Biosciences, Inc.

April 13, 2026
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies

Senti Biosciences, Inc.

April 1, 2026
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Senti Biosciences, Inc.

March 27, 2026
Senti Biosciences to Present Clinical and Translational Data on SENTI-202 at the 11th Annual Innate Killer Conference

Senti Biosciences, Inc.

March 23, 2026
Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference

Senti Biosciences, Inc.

March 3, 2026
Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference

Senti Biosciences, Inc.

February 24, 2026
Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development

Senti Biosciences, Inc.

February 20, 2026
Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

Senti Biosciences, Inc.

February 11, 2026
Senti Biosciences Selected for On-Stage Presentation at Healthcare Conference Taipei 2026

Senti Biosciences, Inc.

February 3, 2026